Table 3 Descriptive statistics of respondents’ (n = 435) attitudes toward using leftover embryos from IVF treatment for treatment, donated by the couple, without financial compensation for the purpose of drug development
Statement | Median (IQR) | 1 Totally agree n (%) | 2 Highly agree n (%) | 3 Partially agree n (%) | 4 Agree to a low degree n (%) | 5 Do not agree at all n (%) |
|---|---|---|---|---|---|---|
It is acceptable to use leftover embryos for treatment of Parkinson’s disease | 1 (1) | 306 (70.3) | 89 (20.5) | 20 (4.6) | 6 (1.4) | 14 (3.2) |
It is acceptable to use leftover embryos for treatment of other types of diseases | 1 (1) | 284 (65.3) | 100 (23.0) | 25 (5.7) | 13 (3.0) | 13 (3.0) |
It is acceptable to use leftover embryos for treatment of diseases but iPS is just as efficient | 2 (2) | 175 (40.2) | 93 (21.4) | 103 (23.7) | 28 (6.4) | 36 (8.4) |